ArticleScientific reports2025
RnaXtract, a tool for extracting gene expression, variants, and cell-type composition from bulk RNA sequencing.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
RNA sequencing (RNA-seq) is a widely used method in transcriptomics research, offering insights into gene expression, variant discovery, and, when deconvoluted, the cellular composition of complex tissues. However, existing RNA-seq pipelines frequently emphasize gene expression analysis and often lack cell deconvolution and variant calling. To address these limitations, we present RnaXtract, a comprehensive and user-friendly pipeline designed to maximize extraction of valuable information from bulk RNA-seq data. RnaXtract automates an entire workflow, encompassing quality control, gene expression quantification, variant calling, and the cell-type deconvolution. Built on the Snakemake framework, RnaXtract ensures robust reproducibility, efficient resource management, and flexibility to adapt to diverse research needs. The pipeline integrates state-of-the-art tools, from quality control to the new updates on variant calling and cell-type deconvolution tools such as EcoTyper and CIBERSORTx, enabling researchers to extract biological insights with precision. By providing an end-to-end solution for bulk RNA-seq, RnaXtract addresses critical gaps in existing workflows, empowering researchers to explore gene expression, genetic variation, and cellular heterogeneity within a single cohesive framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.